Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells

Cellular Signalling

Volumn 25, Issue 1, 2013, Pages 150-158

  Zhang, Xiao Yue ^a   Wu, Xiao Qi ^a   Deng, Rong ^a   Sun, Ting ^a   Feng, Gong Kan ^a   Zhu, Xiao Feng ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Autophagy; Excisanin A; JNK c Jun; Sestrin 2

Indexed keywords

AUTOPHAGY PROTEIN 5; JANUS KINASE 1; JANUS KINASE 2; LUCIFERASE; PROTEIN; PROTEIN C JUN; REGULATOR PROTEIN; SESTRIN 2 PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CANCER CELL; CANCER THERAPY; CELL DEATH; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; UPREGULATION;

AUTOPHAGY; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DITERPENES; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; RNA INTERFERENCE; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84867612825     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.09.004     Document Type: Article

References (47)

1. Budanov A.V., Shoshani T., Faerman A., Zelin E., Kamer I., Kalinski H., Gorodin S., Fishman A., Chajut A., Einat P., Skaliter R., Gudkov A.V., Chumakov P.M., Feinstein E. Oncogene 2002, 21:6017-6031.
2. Velasco-Miguel S., Buckbinder L., Jean P., Gelbert L., Talbott R., Laidlaw J., Seizinger B., Kley N. Oncogene 1999, 18:127-137.
3. McCullough K.D., Martindale J.L., Klotz L.O., Aw T.Y., Holbrook N.J. Molecular and Cellular Biology 2001, 21:1249-1259.
4. Sheikh M.S., Hollander M.C., Fornance A.J. Biochemical Pharmacology 2000, 59:43-45.
5. Takekawa M., Saito H. Cell 1998, 95:521-530.
6. Budanov A.V., Karin M. Cell 2008, 134:451-460.
7. Wang N., Pan W., Zhu M., Zhang M., Hao X., Liang G., Feng Y. British Journal of Pharmacology 2011, 164:731-742.
8. Jung H.J., Kim E.H., Mun J.Y., Park S., Smith M.L., Han S.S., Seo Y.R. Oncogene 2007, 26:7517-7525.
9. Tran H., Brunet A., Grenier J.M., Datta S.R., Fornace A.J., DiStefano P.S., Chiang L.W., Greenberg M.E. Science 2002, 296:530-534.
10. Tong T., Fan W., Zhao H., Jin S., Fan F., Blanck P., Alomo I., Rajasekaran B., Liu Y., Holbrook N.J., Zhan Q. Experimental Cell Research 2001, 269:64-72.
11. Smith M.L., Chen I.T., Zhan Q., Bae I., Chen C.Y., Gilmer T.M., Kastan M.B., O'Connor P.M., Fornace A.J. Science 1994, 266:1376-1380.
12. Sparks C.A., Guertin D.A. Oncogene 2010, 29:3733-3744.
13. Ciuffreda L., Di Sanza C., Incani U.C., Milella M. Current Cancer Drug Targets 2010, 10:484-495.
14. Dancey J. Nature Reviews. Clinical Oncology 2010, 7:209-219.
15. Weston C.R., Davis R.J. Current Opinion in Cell Biology 2007, 19:142-149.
16. Wagner E.F., Nebreda A.R. Nature Reviews. Cancer 2009, 9:537-549.
17. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., Murakami T., Taniguchi M., Tanii I., Yoshinaga K., Shiosaka S., Hammarback J.A., Urano F., Imaizumi K. Molecular and Cellular Biology 2006, 26:9220-9231.
18. Wei Y., Pattingre S., Sinha S., Bassik M., Levine B. Molecular Cell 2008, 30:678-688.
19. Jia G., Cheng G., Gangahar D.M., Agrawal D.K. Immunology and Cell Biology 2006, 84:448-454.
20. Byun J.Y., Yoon C.H., An S., Park I.C., Kang C.M., Kim M.J., Lee S.J. Carcinogenesis 2009, 30:1880-1888.
21. Wong C.H., Iskandar K.B., Yadav S.K., Hirpara J.L., Loh T., Pervaiz S. PLoS One 2010, 5:e9996.
22. Puissant A., Robert G., Fenouille N., Luciano F., Cassuto J.P., Raynaud S., Auberger P. Cancer Research 2010, 70:1042-1052.
23. Lorin S., Borges A., Ribeiro Dos Santos L., Souquere S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. Cancer Research 2009, 69:6924-6931.
24. Li D.D., Wang L.L., Deng R., Tang J., Shen Y., Guo J.F., Wang Y., Xia L.P., Feng G.K., Liu Q.Q., Huang W.L., Zeng Y.X., Zhu X.F. Oncogene 2009, 28:886-898.
25. Deng R., Li W.M., Guan Z., Zhou J.M., Wang Y., Mei Y.P., Li M.T., Feng G.K., Huang W.L., Liu Z.C., Han Y.F., Zeng Y.X., Zhu X.F. Oncogene 2006, 25:7070-7077.
26. Liu J.N., Deng R., Guo J.F., Zhou J.M., Feng G.K., Huang Z.S., Gu L.Q., Zeng Y.X., Zhu X.F. Leukemia 2007, 21:1300-1302.
27. Gururajan M., Chui R., Karuppannan A.K., Ke J., Jennings C.D., Bondada S. Blood 2005, 106:1382-1391.
28. Fujita E., Fujita T., Ito N. Yakugaku Zasshi 1967, 87:1150-1153.
29. Sun H.D., Huang S.X., Han Q.B. Natural Product Reports 2006, 23:673-698.
30. Meade-Tollin L.C., Wijeratne E.M., Cooper D., Guild M., Jon E., Fritz A., Zhou G.X., Whitesell L., Liang J.Y., Gunatilaka A.A. Journal of Natural Products 2004, 67:2-4.
31. Hsieh T.C., Wijeratne E.K., Liang J.Y., Gunatilaka A.L., Wu J.M. Biochemical and Biophysical Research Communications 2005, 337:224-231.
32. Ikezoe T., Yang Y., Bandobashi K., Saito T., Takemoto S., Machida H., Togitani K., Koeffler H.P., Taguchi H. Molecular Cancer Therapeutics 2005, 4:578-586.
33. Bjorkoy G., Lamark T., Pankiv S., Overvatn A., Brech A., Johansen T. Methods in Enzymology 2009, 452:181-197.
34. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M., Baehrecke E.H., Bahr B.A., Ballabio A., Bamber B.A., Bassham D.C., Bergamini E., Bi X., Biard-Piechaczyk M., Blum J.S., Bredesen D.E., Brodsky J.L., Brumell J.H., Brunk U.T., Bursch W., Camougrand N., Cebollero E., Cecconi F., Chen Y., Chin L.S., Choi A., Chu C.T., Chung J., Clarke P.G., Clark R.S., Clarke S.G., Clave C., Cleveland J.L., Codogno P., Colombo M.I., Coto-Montes A., Cregg J.M., Cuervo A.M., Debnath J., Demarchi F., Dennis P.B., Dennis P.A., Deretic V., Devenish R.J., Di Sano F., Dice J.F., Difiglia M., Dinesh-Kumar S., Distelhorst C.W., Djavaheri-Mergny M., Dorsey F.C., Droge W., Dron M., Dunn W.A., Duszenko M., Eissa N.T., Elazar Z., Esclatine A., Eskelinen E.L., Fesus L., Finley K.D., Fuentes J.M., Fueyo J., Fujisaki K., Galliot B., Gao F.B., Gewirtz D.A., Gibson S.B., Gohla A., Goldberg A.L., Gonzalez R., Gonzalez-Estevez C., Gorski S., Gottlieb R.A., Haussinger D., He Y.W., Heidenreich K., Hill J.A., Hoyer-Hansen M., Hu X., Huang W.P., Iwasaki A., Jaattela M., Jackson W.T., Jiang X., Jin S., Johansen T., Jung J.U., Kadowaki M., Kang C., Kelekar A., Kessel D.H., Kiel J.A., Kim H.P., Kimchi A., Kinsella T.J., Kiselyov K., Kitamoto K., Knecht E., et al. Autophagy 2008, 4:151-175.
35. Mizushima N., Yoshimori T., Levine B. Cell 2010, 140:313-326.
36. Lu C., Shi Y., Wang Z., Song Z., Zhu M., Cai Q., Chen T. FEBS Letters 2008, 582:2703-2708.
37. Gagliardi S., Rees M., Farina C. Current Medicinal Chemistry 1999, 6:1197-1212.
38. Mizushima N., Yamamoto A., Hatano M., Kobayashi Y., Kabeya Y., Suzuki K., Tokuhisa T., Ohsumi Y., Yoshimori T. The Journal of Cell Biology 2001, 152:657-668.
39. Kataoka Y., Murley J.S., Patel R., Grdina D.J. International Journal of Radiation Biology 2000, 76:633-639.
40. Maiuri M.C., Malik S.A., Morselli E., Kepp O., Criollo A., Mouchel P.L., Carnuccio R., Kroemer G. Cell Cycle 2009, 8:1571-1576.
41. Dunn C., Wiltshire C., MacLaren A., Gillespie D.A. Cellular Signalling 2002, 14:585-593.
42. Lee J.H., Budanov A.V., Park E.J., Birse R., Kim T.E., Perkins G.A., Ocorr K., Ellisman M.H., Bodmer R., Bier E., Karin M. Science 2010, 327:1223-1228.
43. Budanov A.V. Antioxid Redox Signal 2011, 15:1679-1680.
44. Makris A.M., Kampranis S.C. Cell Death and Differentiation 2005, 12:411-414.
45. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Nature Reviews. Molecular Cell Biology 2007, 8:741-752.
46. Eisenberg-Lerner A., Bialik S., Simon H.U., Kimchi A. Cell Death and Differentiation 2009, 16:966-975.
47. Deng R., Tang J., Xia L.P., Li D.D., Zhou W.J., Wang L.L., Feng G.K., Zeng Y.X., Gao Y.H., Zhu X.F. Molecular Cancer Therapeutics 2009, 8:873-882.